Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A human abuse potential study of oral Rexista

Next Previous
Trial Profile

A human abuse potential study of oral Rexista

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Intellipharmaceutics International

Most Recent Events

  • 10 Oct 2018 According to an Intellipharmaceutics International clinical component of study has been completed. Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
  • 16 Jul 2018 Status changed from planning to recruiting, as reported in the Intellipharmaceutics media release.
  • 16 Jul 2018 According to a an Intellipharmaceutics media release, this trial is underway.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top